Super bread? study tests carob & germ recipe for better blood sugar
NCT ID NCT06200272
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested whether whole-wheat bread enriched with carob molasses pulp and germ can improve blood sugar response and antioxidant capacity in healthy adults. Twenty volunteers aged 19-35 ate both standard and enriched breads, and their blood was tested over three hours. The goal is to see if this bread could help prevent chronic diseases like diabetes and obesity.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- whole-wheat bread enriched with carob molasses pulp and germ
- What this could lead to
- If results are positive, this could point toward a healthier bread option that helps manage blood sugar and boost antioxidants, potentially reducing chronic disease risk.
- What could go wrong
- This is a very small, early study in only 20 healthy people. It does not test long-term effects or disease outcomes, so findings may not apply to the general population or those with health conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * no acute or chronic disease * no prescription drugs and/or nutritional supplements * no pregnant or lactating * no alcohol or excessive alcohol consumption (\<2 drinks/day) * no smoking, * BMI value between 18.5-24.9 kg/m2 * no in the menstrual period for female individuals * no gluten enteropathy * no insulin resistance as a result of endocrinological examination and biochemical tests * no allergic reaction to carob * signed the Informed Volunteer Consent Form * aged between 19 and 35 years. Exclusion Criteria: * having an acute or chronic disease * using prescription drugs and/or nutritional supplements * being in pregnancy and lactation * consuming excessive alcohol (\>2 drinks/day) * smoking * BMI value under 18.5 or above 24.9. kg/m2 * being in the menstrual period for female individuals * having gluten enteropathy * having insulin resistance as a result of endocrinological examination and biochemical tests * having an allergic reaction to carob * not signed the Informed Volunteer Form, * aged under 19 years or above 35 years of age
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy participants are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toros University
Mersin, Yenişehir, 33140, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body